|
1
|
Samsam M, Coveñas R, Ahangari R, Yajeya J,
Narváez JA and Tramu G: Simultaneous depletion of neurokinin A
substance P and calcitonin gene-related peptide from the caudal
trigeminal nucleus of the rat during electrical stimulation of the
trigeminal ganglion. Pain. 84:389–395. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Johnson MB, Young AD and Marriott I: The
therapeutic potential of targeting substance P/NK-1R interactions
in inflammatory CNS disorders. Front Cell Neurosci. 10:2962017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Muñoz M and Coveñas R: Involvement of
substance P and the NK-1 receptor in cancer progression. Peptides.
48:1–9. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ebner K and Singewald N: The role of
substance P in stress and anxiety responses. Amino Acids.
31:251–272. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Garcia-Recio S and Gascón P: Biological
and pharmacological aspects of the NK1-receptor. Biomed Res Int.
2015:4957042015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lieb K, Schaller H, Bauer J, Berger M,
Schulze-Osthoff K and Fiebich BL: Substance P and histamine induce
interleukin-6 expression in human astrocytoma cells by a mechanism
involving protein kinase C and nuclear factor-IL-6. J Neurochem.
70:1577–1583. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lieb K, Fiebich BL, Berger M, Bauer J and
Schulze-Osthoff K: The neuropeptide substance P activates
transcription factor NF-kappa B and kappa B-dependent gene
expression in human astrocytoma cells. J Immunol. 159:4952–4958.
1997.PubMed/NCBI
|
|
8
|
Horuk R, Martin AW, Wang Z, Schweitzer L,
Gerassimides A, Guo H, Lu Z, Hesselgesser J, Perez HD, Kim J, et
al: Expression of chemokine receptors by subsets of neurons in the
central nervous system. J Immunol. 158:2882–2890. 1997.PubMed/NCBI
|
|
9
|
Kim SY, Bae JC, Kim JY, Lee HL, Lee KM,
Kim DS and Cho HJ: Activation of p38 MAP kinase in the rat dorsal
root ganglia and spinal cord following peripheral inflammation and
nerve injury. Neuroreport. 13:2483–2486. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ji RR, Befort K, Brenner GJ and Woolf CJ:
ERK MAP kinase activation in superficial spinal cord neurons
induces prodynorphin and NK-1 upregulation and contributes to
persistent inflammatory pain hypersensitivity. J Neurosci.
22:478–585. 2002.PubMed/NCBI
|
|
11
|
Jin SX, Zhuang ZY, Woolf CJ and Ji RR: p38
mitogen-activated protein kinase is activated after a spinal nerve
ligation in spinal cord microglia and dorsal root ganglion neurons
and contributes to the generation of neuropathic pain. J Neurosci.
23:4017–4022. 2003.PubMed/NCBI
|
|
12
|
Bryans JS and Wustrow DJ: 3-substituted
GABA analogs with central nervous system activity: a review. Med
Res Rev. 19:149–177. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Taylor CP, Gee NS, Su TZ, Kocsis JD, Welty
DF, Brown JP, Dooley DJ, Boden P and Singh L: A summary of
mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res.
29:233–249. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Maneuf YP, Gonzalez MI, Sutton KS, Chung
FZ, Pinnock RD and Lee K: Cellular and molecular action of the
putative GABA-mimetic, gabapentin. Cell Mol Life Sci. 60:742–750.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brown JT and Randall A: Gabapentin fails
to alter P/Q-type Ca2+ channel-mediated synaptic
transmission in the hippocampus in vitro. Synapse. 55:262–269.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
SILLS G: The mechanisms of action of
gabapentin and pregabalin. Curr Opin Pharmacol. 6:108–113. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Maneuf YP, Hughes J and McKnight AT:
Gabapentin inhibits the substance P-facilitated K (+)-evoked
release of [(3)H]glutamate from rat caudial trigeminal nucleus
slices. Pain. 93:191–196. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cunningham MO, Woodhall GL, Thompson SE,
Dooley DJ and Jones RSG: Dual effects of gabapentin and pregabalin
on glutamate release at rat entorhinal synapses in vitro. Eur J
Neurosci. 20:1566–1576. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dooley DJ, Mieske CA and Borosky SA:
Inhibition of K(+)-evoked glutamate release from rat neocortical
and hippocampal slices by gabapentin. Neurosci Lett. 280:107–110.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rosenberg JM, Harrell C, Ristic H, Werner
RA and de Rosayro AM: The effect of gabapentin on neuropathic pain.
Clin J Pain. 13:251–255. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Backonja M, Beydoun A, Edwards KR,
Schwartz SL, Fonseca V, Hes M, LaMoreaux L and Garofalo E:
Gabapentin for the symptomatic treatment of painful neuropathy in
patients with diabetes mellitus: A randomized controlled trial.
JAMA. 280:1831–1836. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rowbotham M, Harden N, Stacey B, Bernstein
P and Magnus-Miller L: Gabapentin for the treatment of postherpetic
neuralgia: A randomized controlled trial. JAMA. 280:1837–1842.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dirks J, Fredensborg BB, Christensen D,
Fomsgaard JS, Flyger H and Dahl JB: A randomized study of the
effects of single-dose gabapentin versus placebo on postoperative
pain and morphine consumption after mastectomy. Anesthesiology.
97:560–564. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Serpell MG; Neuropathic pain study group,
: Gabapentin in neuropathic pain syndromes: A randomised,
double-blind, placebo-controlled trial. Pain. 99:557–566. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Werner MU, Perkins FM, Holte K, Pedersen
JL and Kehlet H: Effects of gabapentin in acute inflammatory pain
in humans. Reg Anesth Pain Med. 26:322–328. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Field MJ, Holloman EF, McCleary S, Hughes
J and Singh L: Evaluation of gabapentin and S-(+)-3-isobutylgaba in
a rat model of postoperative pain. J Pharmacol Exp Ther.
282:1242–1246. 1997.PubMed/NCBI
|
|
27
|
Houghton AK, Lu Y and Westlund KN:
S-(+)-3-isobutylgaba and its stereoisomer reduces the amount of
inflammation and hyperalgesia in an acute arthritis model in the
rat. J Pharmacol Exp Ther. 285:533–538. 1998.PubMed/NCBI
|
|
28
|
Partridge BJ, Chaplan SR, Sakamoto E and
Yaksh TL: Characterization of the effects of gabapentin and
3-isobutyl-gamma-aminobutyric acid on substance P-induced thermal
hyperalgesia. Anesthesiology. 88:196–205. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen SR, Xu Z and Pan HL: Stereospecific
effect of pregabalin on ectopic afferent discharges and neuropathic
pain induced by sciatic nerve ligation in rats. Anesthesiology.
95:1473–1479. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Takasaki I, Andoh T, Nojima H, Shiraki K
and Kuraishi Y: Gabapentin antinociception in mice with acute
herpetic pain induced by herpes simplex virus infection. J
Pharmacol Exp Ther. 296:270–275. 2001.PubMed/NCBI
|
|
31
|
Hunter JC, Gogas KR, Hedley LR, Jacobson
LO, Kassotakis L, Thompson J and Fontana DJ: The effect of novel
anti-epileptic drugs in rat experimental models of acute and
chronic pain. Eur J Pharmacol. 324:153–160. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Stanfa LC, Singh L, Williams RG and
Dickenson AH: Gabapentin, ineffective in normal rats, markedly
reduces C-fibre evoked responses after inflammation. Neuroreport.
8:587–590. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Oku R, Satoh M and Takagi H: Release of
substance P from the spinal dorsal horn is enhanced in
polyarthritic rats. Neurosci Lett. 74:315–319. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fehrenbacher JC, Taylor CP and Vasko MR:
Pregabalin and gabapentin reduce release of substance P and CGRP
from rat spinal tissues only after inflammation or activation of
protein kinase C. Pain. 105:133–141. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Heuillet E, Ménager J, Fardin V, Flamand
O, Bock M, Garret C, Crespo A, Fallourd AM and Doble A:
Characterization of a human NK1 tachykinin receptor in the
astrocytoma cell line U 373 MG. J Neurochem. 60:868–876. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bahrami G and Mohammadi B: Sensitive
microanalysis of gabapentin by high-performance liquid
chromatography in human serum using pre-column derivatization with
4-chloro-7-nitrobenzofurazan: Application to a bioequivalence
study. J Chromatogr B Analyt Technol Biomed Life Sci. 837:24–28.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jalalizadeh H, Souri E, Tehrani MB and
Jahangiri A: Validated HPLC method for the determination of
gabapentin in human plasma using pre-column derivatization with
1-fluoro-2,4-dinitrobenzene and its application to a
pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life
Sci. 854:43–47. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Park S, Ahn ES, Han DW, Lee JH, Min KT,
Kim H and Hong YW: Pregabalin and gabapentin inhibit substance
P-induced NF-kappaB activation in neuroblastoma and glioma cells. J
Cell Biochem. 105:414–423. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tremont-Lukats IW, Megeff C and Backonja
MM: Anticonvulsants for neuropathic pain syndromes: Mechanisms of
action and place in therapy. Drugs. 60:1029–1052. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mao J and Chen LL: Gabapentin in pain
management. Anesth Analg. 91:680–687. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Patel S, Naeem S, Kesingland A, Froestl W,
Capogna M, Urban L and Fox A: The effects of GABA(B) agonists and
gabapentin on mechanical hyperalgesia in models of neuropathic and
inflammatory pain in the rat. Pain. 90:217–226. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Field MJ, Oles RJ, Lewis AS, McCleary S,
Hughes J and Singh L: Gabapentin (neurontin) and
S-(+)-3-isobutylgaba represent a novel class of selective
antihyperalgesic agents. Br J Pharmacol. 121:1513–1522. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Shimoyama N, Shimoyama M, Davis AM,
Inturrisi CE and Elliott KJ: Spinal gabapentin is antinociceptive
in the rat formalin test. Neurosci Lett. 222:65–67. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kaneko M, Mestre C, Sánchez EH and Hammond
DL: Intrathecally administered gabapentin inhibits formalin-evoked
nociception and the expression of Fos-like immunoreactivity in the
spinal cord of the rat. J Pharmacol Exp Ther. 292:743–751.
2000.PubMed/NCBI
|
|
45
|
Field MJ, McCleary S, Hughes J and Singh
L: Gabapentin and pregabalin, but not morphine and amitriptyline,
block both static and dynamic components of mechanical allodynia
induced by streptozocin in the rat. Pain. 80:391–398. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Gajraj NM: Pregabalin: Its pharmacology
and use in pain management. Anesth Analg. 105:1805–1815. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Davies A, Hendrich J, Van Minh AT, Wratten
J, Douglas L and Dolphin AC: Functional biology of the
alpha(2)delta subunits of voltage-gated calcium channels. Trends
Pharmacol Sci. 28:220–228. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Luo ZD, Chaplan SR, Higuera ES, Sorkin LS,
Stauderman KA, Williams ME and Yaksh TL: Upregulation of dorsal
root ganglion (alpha)2(delta) calcium channel subunit and its
correlation with allodynia in spinal nerve-injured rats. J
Neurosci. 21:1868–1875. 2001.PubMed/NCBI
|
|
49
|
Fiebich BL, Schleicher S, Butcher RD,
Craig A and Lieb K: The neuropeptide substance P activates p38
mitogen-activated protein kinase resulting in IL-6 expression
independently from NF-kappa B. J Immunol. 165:5606–5611. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hu P, Bembrick AL, Keay KA and McLachlan
EM: Immune cell involvement in dorsal root ganglia and spinal cord
after chronic constriction or transection of the rat sciatic nerve.
Brain Behav Immun. 21:599–616. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Scholz J, Abele A, Marian C, Häussler A,
Herbert TA, Woolf CJ and Tegeder I: Low-dose methotrexate reduces
peripheral nerve injury-evoked spinal microglial activation and
neuropathic pain behavior in rats. Pain. 138:130–142. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Cao H and Zhang YQ: Spinal glial
activation contributes to pathological pain states. Neurosci
Biobehav Rev. 32:972–983. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Obata K and Noguchi K: MAPK activation in
nociceptive neurons and pain hypersensitivity. Life Sci.
74:2643–2653. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Arruda JL, Colburn RW, Rickman AJ,
Rutkowski MD and DeLeo JA: Increase of interleukin-6 mRNA in the
spinal cord following peripheral nerve injury in the rat: Potential
role of IL-6 in neuropathic pain. Brain Res Mol Brain Res.
62:228–235. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Lee HL, Lee KM, Son SJ, Hwang SH and Cho
HJ: Temporal expression of cytokines and their receptors mRNAs in a
neuropathic pain model. Neuroreport. 15:2807–2811. 2004.PubMed/NCBI
|
|
56
|
Wang XM, Hamza M, Wu TX and Dionne RA:
Upregulation of IL-6, IL-8 and CCL2 gene expression after acute
inflammation: Correlation to clinical pain. Pain. 142:275–283.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wang F, Xu S, Shen X, Guo X, Peng Y and
Yang J: Spinal macrophage migration inhibitory factor is a major
contributor to rodent neuropathic pain-like hypersensitivity.
Anesthesiology. 114:643–659. 2011. View Article : Google Scholar : PubMed/NCBI
|
